Expertise in
1
conditions

Dr. Michael A. Heneghan

Psychiatry
Denver Health And Hospital Authority
777 Bannock St, 
Denver, CO 
Expertise in
1
conditions
Denver Health And Hospital Authority
777 Bannock St, 
Denver, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Heneghan is a Psychiatrist in Denver, Colorado. Dr. Heneghan is highly rated in 1 condition, according to our data. His top areas of expertise are Liver Failure, Delirium, Schizophrenia, Hepato-Pancreato-Biliary Surgery, and Endoscopy.

His clinical research consists of co-authoring 200 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Psychiatry
Licenses
Psychiatry & Neurology in CO
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

DENVER HEALTH AND HOSPITAL AUTHORITY
777 Bannock St, Denver, CO 80204

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
A 52-week, Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Safety and Efficacy of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: August 02, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Assess the Efficacy & Safety of Oral GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid and With Persistently Elevated Alkaline Phosphatase
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Assess the Efficacy & Safety of Oral GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid and With Persistently Elevated Alkaline Phosphatase
Enrollment Status: Completed
Publish Date: June 29, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (PBC) With or Without an Inadequate Response to Ursodeoxycholic Acid (UDCA)
Enrollment Status: Completed
Publish Date: May 18, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

199 Total Publications

Spontaneous Haemorrhagic Gallbladder Rupture Causing Shock in a Background of Primary Sclerosing Cholangitis.
Spontaneous Haemorrhagic Gallbladder Rupture Causing Shock in a Background of Primary Sclerosing Cholangitis.
Journal: Cureus
Published: April 14, 2025
Similar Doctors
Expertise in
17
conditions
Dr. Samantha K. Holden
Psychiatry | Neurology
Expertise in
17
conditions
Dr. Samantha K. Holden
Psychiatry | Neurology

University Physicians Incorporated

12605 E 16th Ave, Uchealth Anschutz Medical, 
Aurora, CO 
 (9.5 miles away)
720-848-0000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Samantha Holden is a Psychiatrist and a Neurologist in Aurora, Colorado. Dr. Holden is highly rated in 17 conditions, according to our data. Her top areas of expertise are Lewy Body Dementia (LBD), Movement Disorders, Parkinson's Disease, and Corticobasal Degeneration. Dr. Holden is currently accepting new patients.

Expertise in
14
conditions
Dr. Rajeev V. Kumar
Neurology | Psychiatry
Expertise in
14
conditions
Dr. Rajeev V. Kumar
Neurology | Psychiatry

Rocky Mountain Movement Disorders Center, P.C.

701 E Hampden Ave, Suite 510, 
Englewood, CO 
 (6.0 miles away)
303-357-5455
Languages Spoken:
English
See accepted insurances

Rajeev Kumar is a Neurologist and a Psychiatrist in Englewood, Colorado. Dr. Kumar is highly rated in 14 conditions, according to our data. His top areas of expertise are Parkinson's Disease, Movement Disorders, Huntington Disease, Lithotripsy, and Pancreaticoduodenectomy.

Expertise in
6
conditions
Dr. Luis G. Allen
Psychiatry
Expertise in
6
conditions
Dr. Luis G. Allen
Psychiatry

Portercare Adventist Health System

7700 S Broadway, Hslh Hospitalists Lah, 
Littleton, CO 
 (11.0 miles away)
303-730-8900
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Luis Allen is a Psychiatrist in Littleton, Colorado. Dr. Allen is highly rated in 6 conditions, according to our data. His top areas of expertise are Major Depression, Bipolar Disorder (BPD), Seasonal Affective Disorder (SAD), and Schizoaffective Disorder. Dr. Allen is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Heneghan's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile